Propylamine

Propylamine

SCHEMBL3378646

CCCN.Cl.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Propylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propylamine SCHEMBL1332318 1.00
Propylamine SCHEMBL187861 1.00
Propylamine SCHEMBL30530502 1.00 DNM1 (0.53)
Propylamine SCHEMBL27850912 1.00 DNM1 (0.53)
Propylamine SCHEMBL30436886 1.00
Propylamine SCHEMBL28605655 1.00 DNM1 (0.53)
Propylamine SCHEMBL30436851 1.00
Propylamine SCHEMBL28524951 0.95
Propylamine SCHEMBL16197458 0.95 DNM1 (0.50)
Propylamine SCHEMBL8379229 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105148559-B Preparation of embedded attapulgite capillary monolithic column and method for using capillary monolithic column for solid phase micro extraction 宁波工程学院 2017-02-01 CN claimed
US-20120264159-A1 SCREENING SYSTEM FOR MODULATORS OF HER2 MEDIATED TRANSCRIPTION AND HER2 MODULATORS IDENTIFED THEREBY BUCK INSTITUTE FOR AGE RESEARCH (US) 2012-10-18 US claimed
EP-2155152-A2 COLOURING COMPOSITION COMPRISING AN AMINOPYRAZOLOPYRIDINE OXIDATION BASE AND EXHIBITING AN ACIDIC PH L'Oreal (FR) 2010-02-24 EP claimed
WO-2008138845-A2 COLOURING COMPOSITION COMPRISING AN AMINOPYRAZOLOPYRIDINE OXIDATION BASE AND EXHIBITING AN ACIDIC PH L'OREAL (FR) 2008-11-20 WO claimed
US-20050123896-A1 Screening system for modulators of her2 mediated transcription and her2 modulators identified thereby BUCK INSTITUTE FOR AGE RESEARCH 2005-06-09 US claimed
WO-2003035843-A2 SCREENING SYSTEM FOR MODULATORS OF HER2 MEDIATED TRANSCRIPTION AND HER2 MODULATORS IDENTIFED THEREBY BUCK INSTITUTE FOR AGE RESEARCH (US) 2003-05-01 WO claimed
US-20250127898-A1 PHOTODYNAMIC THERAPY AND DIAGNOSIS Invion Limited (AU) 2025-04-24 US disclosed
WO-2024246764-A1 NOVEL BENZAMIDE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 삼진제약주식회사 2024-12-05 WO disclosed
EP-4436973-A1 PHOTODYNAMIC THERAPY AND DIAGNOSIS RMW Cho Group Limited (HK) 2024-10-02 EP disclosed
CN-118591543-A Photodynamic therapy and diagnosis RMW曹氏集团有限公司 2024-09-03 CN disclosed
WO-2023094680-A1 PHOTODYNAMIC THERAPY AND DIAGNOSIS RMW CHO GROUP LIMITED (CN) 2023-06-01 WO disclosed
CN-116134056-A Aqueous polymer latex suitable as film-forming copolymer for binders in aqueous coating compositions 巴斯夫欧洲公司 2023-05-16 CN disclosed
CN-106795100-B Compound, pharmaceutical composition and its purposes in treatment neurodegenerative disease 里尔大学 2019-11-19 CN disclosed
EP-0035901-B1 HAIR CONDITIONING COMPOSITION AND METHOD OF CONDITIONING HAIR THEREWITH THE PROCTER &amp; GAMBLE COMPANY (US) 1984-05-30 EP disclosed
US-4387090-A HYDROCARBONS, SILICONES AND HYDROPHOBIC THICKENER THE PROCTER & GAMBLE COMPANY (US) 1983-06-07 US disclosed
US-4374825-A HYDROCARBON AND/OR SILICONE, NONIONIC POLYMER, QUATERNARY AMMONIUM OR FATTY AMINE SALT THE PROCTOR & GAMBLE COMPANY (US) 1983-02-22 US disclosed
EP-0035899-A2 Hair conditioning composition and method of conditioning hair therewith THE PROCTER &amp; GAMBLE COMPANY (US) 1981-09-16 EP disclosed
EP-0035901-A2 Hair conditioning composition and method of conditioning hair therewith THE PROCTER &amp; GAMBLE COMPANY (US) 1981-09-16 EP disclosed
US-4206195-A ALUMINUM COMPOUND, ZIRCONIUM COMPOUND, AND A MANGANESE COMPOUND PLUS A POTASSIUM, SODIUM, AMMONIUM, OR MAGNESIUM COMPOUND THE PROCTER & GAMBLE COMPANY (US) 1980-06-03 US disclosed
US-4206196-A Hair conditioning article and a method of its use THE PROCTER & GAMBLE COMPANY (US) 1980-06-03 US disclosed